|
Delayed
Australian S.E.
02:34:44 07/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.3000 AUD | -4.76% |
|
-4.76% | -53.85% |
| 08-31 | Recce Pharmaceuticals Ltd Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-30 | Recce Pharmaceuticals Ltd Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 96.32M 67.25M 59.69M 55.86M 50.63M 95.63M 6.48B 671M 261M 3.31B 252M 247M 10.63B | P/E 2027 * |
-3.71x | P/E 2028 * | 2.84x |
|---|---|---|---|---|---|
| Enterprise Value | 121M 84.68M 75.17M 70.34M 63.76M 120M 8.16B 845M 329M 4.16B 318M 311M 13.39B | EV / Sales 2027 * |
9.71x | EV / Sales 2028 * | 0.89x |
| Free-Float |
62.73% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| RCE | Delayed | |
Deutsche Boerse AG
| R9Q | Delayed | |
|
Börse Stuttgart
| R9Q | Delayed | |
|
Boerse Muenchen
| R9Q | Real-time | |
|
Tradegate
| R9Q | Real-time |
| 1 day | -4.76% | ||
| 1 week | -4.76% | ||
| Current month | -4.76% | ||
| 1 month | -16.67% | ||
| 3 months | -21.05% | ||
| 6 months | -34.07% | ||
| Current year | -53.85% |
| 1 week | 0.29 |  | 0.32 |
| 1 month | 0.29 | | 0.37 |
| Current year | 0.29 | | 0.73 |
| 1 year | 0.29 | | 0.73 |
| 3 years | 0.28 | | 0.73 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 27/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 29/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 30/09/2012 |
James Graham
BRD | Director/Board Member | - | 30/04/2012 |
| Director/Board Member | - | 31/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/07/26 | Buy | Chief Executive Officer | 25,000 | 0.0083% | ||
| 31/07/26 | Buy | Director | 75,000 | 0.0250% | ||
| 31/07/26 | Buy | Director | 37,500 | 0.0125% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.76% | -4.76% | -28.57% | -31.82% | 64.99M | |
| +1.26% | -2.29% | +36.97% | +104.79% | 1,019B | |
| +0.73% | -4.78% | +35.41% | +61.62% | 610B | |
| +0.35% | +1.29% | +15.86% | +79.90% | 470B | |
| +1.72% | -4.92% | +59.84% | +36.64% | 344B | |
| +0.26% | +0.14% | +21.29% | +40.99% | 336B | |
| +0.60% | -3.09% | +10.76% | +32.59% | 266B | |
| +1.65% | -3.78% | -6.03% | +9.29% | 241B | |
| -0.09% | -4.97% | +36.88% | +50.52% | 218B | |
| -0.28% | -4.66% | +26.99% | +92.98% | 179B | |
| Average | -0.14% | -4.10% | +20.94% | +47.75% | 368.29B | |
| Weighted average by Cap. | +0.05% | -3.43% | +29.52% | +67.02% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 12.5M 8.72M 7.74M 7.25M 6.57M 12.41M 841M 87.04M 33.85M 429M 32.75M 32.04M 1.38B | 54.3M 37.91M 33.65M 31.49M 28.55M 53.91M 3.65B 378M 147M 1.86B 142M 139M 5.99B |
| Net income | -25.1M -17.52M -15.56M -14.56M -13.19M -24.92M -1.69B -175M -68M -862M -65.78M -64.36M -2.77B | 33.4M 23.32M 20.7M 19.37M 17.56M 33.16M 2.25B 233M 90.49M 1.15B 87.53M 85.65M 3.69B |
| Net Debt | 24.96M 17.43M 15.47M 14.48M 13.12M 24.78M 1.68B 174M 67.63M 857M 65.42M 64.02M 2.76B | -48.1M -33.58M -29.81M -27.9M -25.29M -47.75M -3.24B -335M -130M -1.65B -126M -123M -5.31B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/10/26 | A$0.3000 | -4.76% | 7,658 |
| 06/10/26 | A$0.3150 | +3.28% | 339,051 |
| 05/10/26 | A$0.3050 | -6.15% | 121,963 |
| 02/10/26 | A$0.3250 | +4.84% | 138,718 |
| 01/10/26 | A$0.3100 | -1.59% | 18,813 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
